Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02923037 · ClinicalTrials.gov registry record · NA
Hatha Yoga in Breast Cancer Survivors
A NA study, sponsored by Vanderbilt-Ingram Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT02923037 is a NA study that was terminated before completion, run by Vanderbilt-Ingram Cancer Center. The registered enrollment target is 27 participants.
The verdict
NCT02923037, a NA study, was terminated before completion, sponsored by Vanderbilt-Ingram Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
This pilot clinical trial studies Hatha yoga in reducing physical and emotional problems in breast cancer survivors with stage II-III lymphedema. Yoga practices may benefit breast cancer survivors with lymphedema as they directly support lymph transport (postures, breathing, relaxation) and emotional well-being (relaxation, meditation).
Interventions
- OTHER Quality-of-Life Assessment
- PROCEDURE Yoga
- OTHER tape measurement of arm
- OTHER ldex measurement of arms
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2016-09-01 |
| Est. Completion | 2019-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02923037
The ClinicalTrials.gov registry entry for NCT02923037 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt-Ingram Cancer Center, which has 189 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.
NCT02923037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02923037 about?
NCT02923037 is a clinical study titled "Hatha Yoga in Breast Cancer Survivors". This pilot clinical trial studies Hatha yoga in reducing physical and emotional problems in breast cancer survivors with stage II-III lymphedema. Yoga practices may benefit breast cancer survivors with lymphedema as they directly support lymph transport (postures, breathing, relaxation) and emotiona...
What is the current status of trial NCT02923037?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2016-09-01. Estimated completion is 2019-03.
What interventions are being tested in trial NCT02923037?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Yoga (PROCEDURE), tape measurement of arm (OTHER), ldex measurement of arms (OTHER).
Who is sponsoring clinical trial NCT02923037?
This trial is sponsored by Vanderbilt-Ingram Cancer Center, which has 189 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.